Biohaven (BHVN) Invested Capital (2021 - 2026)

Biohaven has disclosed Invested Capital across 6 years of filings, most recently posting $129.5 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $129.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $129.5 million (changed N/A YoY), and the FY2025 annual result was $52.1 million, up 65813.92% from the prior year.
• Invested Capital came in at $129.5 million for Q1 2026 at Biohaven, up from $52.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $538.8 million in Q4 2022 to a low of -$1.2 billion in Q3 2024.
• The 5-year median for Invested Capital is $12.6 million (2022), against an average of $18.8 million.
• Across the five-year window, Invested Capital sank 1379508.33% in 2024 and jumped 209458.67% in 2025, its largest moves.
• Biohaven's Invested Capital stood at $538.8 million in 2022, then dropped by 20.56% to $428.0 million in 2023, then tumbled by 99.98% to $79000.0 in 2024, then surged by 65813.92% to $52.1 million in 2025, then soared by 148.69% to $129.5 million in 2026.
• The last three Invested Capital figures came in at $129.5 million (Q1 2026), $52.1 million (Q4 2025), and -$17.2 million (Q3 2025), per Business Quant data.